291 related articles for article (PubMed ID: 30208519)
1. Engineering of a tumor cell-specific, cytosol-penetrating antibody with high endosomal escape efficacy.
Kim JS; Park JY; Shin SM; Park SW; Jun SY; Hong JS; Choi DK; Kim YS
Biochem Biophys Res Commun; 2018 Sep; 503(4):2510-2516. PubMed ID: 30208519
[TBL] [Abstract][Full Text] [Related]
2. A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells.
Choi DK; Bae J; Shin SM; Shin JY; Kim S; Kim YS
MAbs; 2014; 6(6):1402-14. PubMed ID: 25484049
[TBL] [Abstract][Full Text] [Related]
3. Endosomal acidic pH-induced conformational changes of a cytosol-penetrating antibody mediate endosomal escape.
Kim JS; Choi DK; Shin JY; Shin SM; Park SW; Cho HS; Kim YS
J Control Release; 2016 Aug; 235():165-175. PubMed ID: 27264553
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of cellular uptake and cytosolic access of antibody in living cells by an enhanced split GFP complementation assay.
Kim JS; Choi DK; Park SW; Shin SM; Bae J; Kim DM; Yoo TH; Kim YS
Biochem Biophys Res Commun; 2015 Nov; 467(4):771-7. PubMed ID: 26482850
[TBL] [Abstract][Full Text] [Related]
5. Cell-penetrating mechanism of intracellular targeting albumin: Contribution of macropinocytosis induction and endosomal escape.
Ichimizu S; Watanabe H; Maeda H; Hamasaki K; Ikegami K; Chuang VTG; Kinoshita R; Nishida K; Shimizu T; Ishima Y; Ishida T; Seki T; Katsuki H; Futaki S; Otagiri M; Maruyama T
J Control Release; 2019 Jun; 304():156-163. PubMed ID: 31082432
[TBL] [Abstract][Full Text] [Related]
6. Endosomal escape efficiency of fusogenic B18 and B55 peptides fused with anti-EGFR single chain Fv as estimated by nuclear translocation.
Niikura K; Horisawa K; Doi N
J Biochem; 2016 Jan; 159(1):123-32. PubMed ID: 26338729
[TBL] [Abstract][Full Text] [Related]
7. HOPS-dependent endosomal fusion required for efficient cytosolic delivery of therapeutic peptides and small proteins.
Steinauer A; LaRochelle JR; Knox SL; Wissner RF; Berry S; Schepartz A
Proc Natl Acad Sci U S A; 2019 Jan; 116(2):512-521. PubMed ID: 30610181
[TBL] [Abstract][Full Text] [Related]
8. Plasma membrane depolarization reveals endosomal escape incapacity of cell-penetrating peptides.
Serulla M; Anees P; Hallaj A; Trofimenko E; Kalia T; Krishnan Y; Widmann C
Eur J Pharm Biopharm; 2023 Mar; 184():116-124. PubMed ID: 36709921
[TBL] [Abstract][Full Text] [Related]
9. Cytosolic Delivery of Macromolecules in Live Human Cells Using the Combined Endosomal Escape Activities of a Small Molecule and Cell Penetrating Peptides.
Allen J; Najjar K; Erazo-Oliveras A; Kondow-McConaghy HM; Brock DJ; Graham K; Hager EC; Marschall ALJ; Dübel S; Juliano RL; Pellois JP
ACS Chem Biol; 2019 Dec; 14(12):2641-2651. PubMed ID: 31633910
[TBL] [Abstract][Full Text] [Related]
10. The cell-type specificity and endosomal escape of cell-penetrating peptides.
Feng J; Tang L
Curr Pharm Des; 2015; 21(10):1351-6. PubMed ID: 25341672
[TBL] [Abstract][Full Text] [Related]
11. Engineering of an EpCAM-targeting cyclic peptide to improve the EpCAM-mediated cellular internalization and tumor accumulation of a peptide-fused antibody.
Park SW; Jun SY; Kim JS; Kim YS
Biochem Biophys Res Commun; 2021 Oct; 573():35-41. PubMed ID: 34388452
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Cellular Uptake, Endosomal Escape, and Cytosolic Entry Efficiencies of Cyclic Peptides.
Salim H; Pei D
Methods Mol Biol; 2022; 2371():301-316. PubMed ID: 34596855
[TBL] [Abstract][Full Text] [Related]
13. A real-time assay for cell-penetrating peptide-mediated delivery of molecular cargos.
Gentry SB; Nowak SJ; Ni X; Hill SA; Wade LR; Clark WR; Keelaghan AP; Morris DP; McMurry JL
PLoS One; 2021; 16(9):e0254468. PubMed ID: 34473728
[TBL] [Abstract][Full Text] [Related]
14. Engineered Histidine-Rich Peptides Enhance Endosomal Escape for Antibody-Targeted Intracellular Delivery of Functional Proteins.
Zhao Y; Jiang H; Yu J; Wang L; Du J
Angew Chem Int Ed Engl; 2023 Sep; 62(38):e202304692. PubMed ID: 37283024
[TBL] [Abstract][Full Text] [Related]
15. Early endosomal escape of a cyclic cell-penetrating peptide allows effective cytosolic cargo delivery.
Qian Z; LaRochelle JR; Jiang B; Lian W; Hard RL; Selner NG; Luechapanichkul R; Barrios AM; Pei D
Biochemistry; 2014 Jun; 53(24):4034-46. PubMed ID: 24896852
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics.
Lönn P; Kacsinta AD; Cui XS; Hamil AS; Kaulich M; Gogoi K; Dowdy SF
Sci Rep; 2016 Sep; 6():32301. PubMed ID: 27604151
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a Cyclic Cell-Penetrating Peptide with Improved Endosomal Escape and Cytosolic Delivery Efficiency.
Buyanova M; Sahni A; Yang R; Sarkar A; Salim H; Pei D
Mol Pharm; 2022 May; 19(5):1378-1388. PubMed ID: 35405068
[TBL] [Abstract][Full Text] [Related]
18. Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay.
Teo SLY; Rennick JJ; Yuen D; Al-Wassiti H; Johnston APR; Pouton CW
Nat Commun; 2021 Jun; 12(1):3721. PubMed ID: 34140497
[TBL] [Abstract][Full Text] [Related]
19. Variable Heavy Chain Domain Derived from a Cell-Penetrating Anti-DNA Monoclonal Antibody for the Intracellular Delivery of Biomolecules.
Im SW; Pravinsagar P; Im SR; Jang YJ
Immunol Invest; 2017 Jul; 46(5):500-517. PubMed ID: 28388234
[TBL] [Abstract][Full Text] [Related]
20. A Conditionally Activated Cytosol-Penetrating Antibody for TME-Dependent Intracellular Cargo Delivery.
Dombrowsky CS; Happel D; Habermann J; Hofmann S; Otmi S; Cohen B; Kolmar H
Antibodies (Basel); 2024 May; 13(2):. PubMed ID: 38804305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
